Matrix metalloproteinases in the mouse retina: a comparative study of expression patterns and MMP antibodies

Lies De Groef1, Lien Andries2, Kim Lemmens3

  • 1Laboratory of Neural Circuit Development and Regeneration, Animal Physiology and Neurobiology Section, Department of Biology; KU Leuven, Naamsestraat 61, Box 2464, B-3000, Leuven, Belgium. lies.degroef@bio.kuleuven.be.

BMC Ophthalmology
|December 31, 2015
PubMed
Abstract

Insights

This study maps the expression of matrix metalloproteinases (MMPs) in healthy mouse retinas. Findings reveal specific MMP locations, aiding research into retinal diseases like glaucoma.

Area of Science:

  • Ophthalmology and Neuroscience
  • Molecular and Cellular Biology
  • Enzyme Function and Regulation

Background:

  • Matrix metalloproteinases (MMPs) are critical regulators in physiological and pathological processes.
  • While essential for ocular health, aberrant MMP activity is implicated in retinal neurodegenerative diseases such as glaucoma.
  • Current understanding of MMP roles in glaucomatous optic neuropathies (GONs) is limited, with a need for detailed expression profiling.

Purpose of the Study:

  • To investigate the spatial expression patterns of MMP-2, MMP-3, MMP-9, and MT1-MMP in the healthy adult mouse retina.
  • To establish a baseline understanding of MMP distribution to facilitate future studies on ocular pathologies.
  • To validate the specificity and sensitivity of commercially available MMP antibodies for retinal research.

Main Methods:

  • Immunohistochemical staining was employed to determine the spatial expression of MMP-2, MMP-3, MMP-9, and MT1-MMP in healthy mouse retinas.
  • Western blot analysis was performed to assess the sensitivity and specificity of antibodies used for MMP detection.
  • Expression profiles were compared with existing literature and validated across different species and developmental stages where applicable.

Main Results:

  • Basal expression of MMP-2, MMP-3, MMP-9, and MT1-MMP was detected in healthy adult mouse retinas.
  • MMP-2 localized to Müller glia end feet; MMP-3 was newly identified in Müller glia radial fibers; MMP-9 was found in microglia and apoptotic retinal ganglion cells (RGCs).
  • MT1-MMP was observed in RGC axons and Müller glia, consistent with patterns in rabbits and neonatal mice. Antibody validation confirmed selection of one antibody per MMP.

Conclusions:

  • The established MMP immunoreactivity profiles provide a crucial foundation for studying MMP expression in mouse models of retinal diseases.
  • These findings will enable comparative analysis between experimental models and clinical observations, aiding in understanding MMPs' roles in ocular pathologies.
  • This work represents a significant first step toward clarifying the precise functions of MMPs in the pathogenesis and resolution of retinal diseases.